Remote health monitoring company Empatica has officially launched its next-generation wearable epilepsy monitoring watch, EpiMonitor.
EpiMonitor is said to be an all-in-one epilepsy monitoring solution that provides patients and doctors with continuous, accurate health insights.
Related: KORE and Medical Guardian Collaborate to Launch First eSIM-Powered Medical Alert Device
It also detects and alerts for seizures using Empatica’s next-generation medical watch, EmbracePlus, and a companion smartphone app.
The product has been cleared by the US Food and Drug Administration (FDA) for use in adult and children populations aged six and more.
EpiMonitor is now said to be the only commercially available wearable solution with regulatory approval for seizure detection in the US.
It is the successor for Embrace2, which was the first wearable to be made available to patients for seizure detection, Empatica said.
EpiMonitor’s improved features, such as additional seizure alarm features, battery life of up to a week, and better health insights, are said to represent a major advancement in epilepsy monitoring technologies.
The system continuously monitors its wearer’s health data, detects possible generalised tonic-clonic seizures, alerts caregivers, and provides useful health information to help users better manage their condition.
Additionally, the epilepsy monitoring watch has advanced sensor technology for accurate data collection and an option to send self-triggered alarms to caregivers.
EpiMonitor, compatible with iOS and Android, also tracks sleep and activities via Empatica’s smart algorithms.
Empatica chief scientist and co-founder Rosalind Picard said: “Empatica has always provided the only smartwatch seizure monitors validated by the FDA. EpiMonitor takes this to a new level: giving patients up to seven days of battery life, and new features that give them greater control over seizure alerts.
“Also, at the touch of a button, patients can now see comprehensive health insights – including seizures, sleep, and activity reports – in a form easy to give their clinician. EpiMonitor is the device we’ve long dreamed of to open a new era in giving epilepsy patients greater control over their lives.”
In a similar development, the remote health monitoring company launched its artificial intelligence (AI)-based study to develop a seizure forecasting algorithm.
The recruitment for the study is now open to all EpiMonitor users in the US.
Empatica said that seizure forecasting can help in early intervention in the form of customised therapies and better managing its treatment.
